Developing and commercializing first-in-class, well-characterized drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies.
In The News
Something went wrong: cURL error 28: Operation timed out after 5000 milliseconds with 0 bytes received
SEE ALL